Khalid Muhammad

InstitutionUnited Arab Emirates University
AddressGermany
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 7 Covid-19 publications, with a maximum of 2 publications in March 2021
    All Publications
    Bar chart showing 38 publications over 15 distinct years, with a maximum of 5 publications in 2015 and 2016
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Hetta HF, Muhammad K, Algammal AM, Ramadan H, Abdel-Rahman MS, Mabrok M, Koneru G, Elkady AA, El-Saber Batiha G, Waheed Y, Munawar N, Farghaly HSM. Mapping the effect of drugs on ACE2 as a novel target site for COVID-19 therapy. Eur Rev Med Pharmacol Sci. 2021 May; 25(10):3923-3932. PMID: 34109607.
      Citations:    Fields:    Translation:Humans
    2. Koneru G, Batiha GE, Algammal AM, Mabrok M, Magdy S, Sayed S, AbuElmagd ME, Elnemr R, Saad MM, Abd Ellah NH, Hosni A, Muhammad K, Hetta HF. BCG Vaccine-Induced Trained Immunity and COVID-19: Protective or Bystander? Infect Drug Resist. 2021; 14:1169-1184. PMID: 33790587.
      Citations: 1     
    3. Ahmad S, Waheed Y, Ismail S, Bhatti S, Abbasi SW, Muhammad K. Structure-Based Virtual Screening Identifies Multiple Stable Binding Sites at the RecA Domains of SARS-CoV-2 Helicase Enzyme. Molecules. 2021 Mar 07; 26(5). PMID: 33800013.
      Citations: 3     Fields:    Translation:HumansAnimalsCells
    4. Hetta HF, Muhammad K, El-Masry EA, Taha AE, Ahmed EA, Phares C, Kader HA, Waheed Y, Zahran AM, Yahia R, Meshaal AK, El-Saber Batiha G. The interplay between vitamin D and COVID-19: protective or bystander? Eur Rev Med Pharmacol Sci. 2021 02; 25(4):2131-2145. PMID: 33660833.
      Citations: 1     Fields:    Translation:Humans
    5. Dar HA, Waheed Y, Najmi MH, Ismail S, Hetta HF, Ali A, Muhammad K. Multiepitope Subunit Vaccine Design against COVID-19 Based on the Spike Protein of SARS-CoV-2: An In Silico Analysis. J Immunol Res. 2020; 2020:8893483. PMID: 33274246.
      Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
    6. Mahmood Z, Alrefai H, Hetta HF, A Kader H, Munawar N, Abdul Rahman S, Elshaer S, Batiha GE, Muhammad K. Investigating Virological, Immunological, and Pathological Avenues to Identify Potential Targets for Developing COVID-19 Treatment and Prevention Strategies. Vaccines (Basel). 2020 Aug 06; 8(3). PMID: 32781571.
      Citations: 4     
    7. Abd Ellah NH, Gad SF, Muhammad K, E Batiha G, Hetta HF. Nanomedicine as a promising approach for diagnosis, treatment and prophylaxis against COVID-19. Nanomedicine (Lond). 2020 09; 15(21):2085-2102. PMID: 32723142.
      Citations: 25     Fields:    Translation:HumansCellsPHPublic Health